Clinical Trial Update: IcoSApent ethyL to Slow Down Aortic VAlve Stenosis proGrEssion [Phase 2]

View source ↗

Summary

A Phase 2 trial update examining whether icosapent ethyl can slow progression of aortic valve stenosis; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Valve Stenosis

Drugs mentioned

• ICOSAPENT ETHYL (icosapent ethyl)

Snippet

Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | Conditions: Aortic Valve Stenosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING